Mutations in Noncoding


Journal

Molecular cancer research : MCR
ISSN: 1557-3125
Titre abrégé: Mol Cancer Res
Pays: United States
ID NLM: 101150042

Informations de publication

Date de publication:
01 2022
Historique:
received: 17 06 2021
revised: 31 07 2021
accepted: 17 09 2021
pubmed: 25 9 2021
medline: 31 3 2022
entrez: 24 9 2021
Statut: ppublish

Résumé

Whole-genome sequencing of primary breast tumors enabled the identification of cancer driver genes and noncoding cancer driver plexuses from somatic mutations. However, differentiating driver from passenger events among noncoding genetic variants remains a challenge. Herein, we reveal cancer-driver

Identifiants

pubmed: 34556523
pii: 1541-7786.MCR-21-0471
doi: 10.1158/1541-7786.MCR-21-0471
pmc: PMC9398156
doi:

Substances chimiques

Chromatin 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

102-113

Subventions

Organisme : CIHR
ID : 136963
Pays : Canada
Organisme : CIHR
ID : 158225
Pays : Canada
Organisme : CIHR
ID : 168933
Pays : Canada

Informations de copyright

©2021 The Authors; Published by the American Association for Cancer Research.

Références

Nat Genet. 2016 Jan;48(1):12-21
pubmed: 26618344
Breast. 2014 Oct;23(5):623-8
pubmed: 24993072
Nat Genet. 2013 Oct;45(10):1113-20
pubmed: 24071849
PLoS Genet. 2017 May 10;13(5):e1006773
pubmed: 28489852
Proc Natl Acad Sci U S A. 2013 Apr 9;110(15):6021-6
pubmed: 23530248
Mol Cell. 2020 Mar 19;77(6):1307-1321.e10
pubmed: 31954095
Nucleic Acids Res. 2006 Jul 1;34(Web Server issue):W551-4
pubmed: 16845068
J Clin Oncol. 1999 May;17(5):1474-81
pubmed: 10334533
Science. 2013 Feb 22;339(6122):957-9
pubmed: 23348506
Nat Rev Genet. 2011 Dec 06;13(1):59-69
pubmed: 22143240
Genome Res. 2013 Jan;23(1):12-22
pubmed: 23172872
J Pathol. 2009 Jan;217(1):32-41
pubmed: 18825690
Nature. 2016 Apr 14;532(7598):259-63
pubmed: 27075100
Oncol Lett. 2017 Aug;14(2):1247-1264
pubmed: 28789340
Surg Oncol Clin N Am. 2018 Jan;27(1):95-120
pubmed: 29132568
Nature. 2012 Jan 04;481(7381):389-93
pubmed: 22217937
PLoS Genet. 2017 Sep 28;13(9):e1006761
pubmed: 28957321
Cell. 2008 Mar 21;132(6):958-70
pubmed: 18358809
Science. 2013 Feb 22;339(6122):959-61
pubmed: 23348503
PLoS One. 2016 Apr 21;11(4):e0150434
pubmed: 27100180
Saudi Pharm J. 2020 May;28(5):607-614
pubmed: 32435142
Nat Genet. 2013 Apr;45(4):371-84, 384e1-2
pubmed: 23535731
Nat Genet. 2014 Jan;46(1):61-64
pubmed: 24212882
Nat Commun. 2014 Sep 23;4:4999
pubmed: 25248036
Bioinformatics. 2009 Dec 1;25(23):3181-2
pubmed: 19773334
Nat Genet. 2014 Dec;46(12):1258-63
pubmed: 25383969
Nature. 2016 May 02;534(7605):47-54
pubmed: 27135926
Science. 2006 Oct 13;314(5797):268-74
pubmed: 16959974
Oncogene. 2008 Aug 28;27(37):5033-44
pubmed: 18454173
Proc Natl Acad Sci U S A. 1992 Jul 15;89(14):6300-3
pubmed: 1631121
N Engl J Med. 1995 Nov 2;333(18):1171-5
pubmed: 7565971
Nat Genet. 2011 Jan;43(1):27-33
pubmed: 21151129
Curr Protoc Mol Biol. 2015 Jan 05;109:21.29.1-21.29.9
pubmed: 25559105
Nat Genet. 2016 Oct;48(10):1260-6
pubmed: 27571262
Nat Cancer. 2020 Apr;1(4):452-468
pubmed: 35121966
Nucleic Acids Res. 2020 May 21;48(9):4756-4768
pubmed: 32232341
Nat Methods. 2013 Dec;10(12):1213-8
pubmed: 24097267
Genome Biol. 2020 Jan 7;21(1):8
pubmed: 31910858
J Biol Chem. 1996 Sep 6;271(36):22076-80
pubmed: 8703016
Cell Death Dis. 2015 Feb 26;6:e1658
pubmed: 25719243
NPJ Breast Cancer. 2019 Nov 29;5:45
pubmed: 31815181
Proc Natl Acad Sci U S A. 2005 Oct 25;102(43):15545-50
pubmed: 16199517
Nat Genet. 2012 Nov;44(11):1191-8
pubmed: 23001124
Genome Biol. 2008;9(9):R137
pubmed: 18798982
Biochem Biophys Res Commun. 2017 Oct 21;492(3):425-433
pubmed: 28842253
Curr Cancer Drug Targets. 2019;19(7):515-524
pubmed: 30338738
Cell. 2019 Mar 21;177(1):101-114
pubmed: 30901533
Breast Cancer Res Treat. 2008 Feb;107(3):337-47
pubmed: 17393299
Curr Med Chem. 2015;22(2):264-89
pubmed: 25386819
Science. 2018 Oct 26;362(6413):
pubmed: 30361341
Nat Cancer. 2020 Sep;1(9):864-872
pubmed: 35121955
Cancer Cell. 2019 Dec 9;36(6):674-689.e6
pubmed: 31735626
Mutat Res Rev Mutat Res. 2017 Jan - Mar;771:15-31
pubmed: 28342451
Nature. 2020 Feb;578(7793):102-111
pubmed: 32025015
Cancer Cell. 2014 Jun 16;25(6):748-61
pubmed: 24835590
Nat Genet. 2017 Dec;49(12):1779-1784
pubmed: 29083409
Nature. 2017 Jul 6;547(7661):55-60
pubmed: 28658208
Nat Rev Cancer. 2020 Oct;20(10):555-572
pubmed: 32778778
Nature. 2016 Apr 14;532(7598):264-7
pubmed: 27075101
Biochim Biophys Acta. 2014 Oct;1842(10):1910-1922
pubmed: 24667321
Nucleic Acids Res. 2020 Jan 8;48(D1):D180-D188
pubmed: 31665499
Thyroid. 2020 Nov;30(11):1589-1600
pubmed: 32326836
Nat Genet. 2015 Jul;47(7):818-21
pubmed: 26053496
Science. 2007 Nov 16;318(5853):1108-13
pubmed: 17932254
Nat Commun. 2020 Jan 23;11(1):441
pubmed: 31974375

Auteurs

Samah El Ghamrasni (S)

Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.

Rene Quevedo (R)

Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.
Department of Medical Biophysics, University of Toronto, Toronto, Ontario, Canada.

James Hawley (J)

Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.
Department of Medical Biophysics, University of Toronto, Toronto, Ontario, Canada.

Parisa Mazrooei (P)

Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.
Department of Medical Biophysics, University of Toronto, Toronto, Ontario, Canada.
Genentech, South San Francisco, California.

Youstina Hanna (Y)

Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.

Iulia Cirlan (I)

Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.

Helen Zhu (H)

Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.
Department of Medical Biophysics, University of Toronto, Toronto, Ontario, Canada.
Vector Institute, Toronto, Ontario, Canada.
Ontario Institute for Cancer Research, Toronto, Ontario, Canada.

Jeff P Bruce (JP)

Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.

Leslie E Oldfield (LE)

Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.

S Y Cindy Yang (SYC)

Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.
Department of Medical Biophysics, University of Toronto, Toronto, Ontario, Canada.

Paul Guilhamon (P)

Developmental and Stem Cell Biology Program, The Hospital for Sick Children, Toronto, Ontario, Canada.
Arthur and Sonia Labatt Brain Tumor Research Centre, The Hospital for Sick Children, Toronto, Ontario, Canada.

Jüri Reimand (J)

Department of Medical Biophysics, University of Toronto, Toronto, Ontario, Canada.
Ontario Institute for Cancer Research, Toronto, Ontario, Canada.
Department of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada.

Dave W Cescon (DW)

Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.

Susan J Done (SJ)

Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.
Department of Medical Biophysics, University of Toronto, Toronto, Ontario, Canada.
Department of Laboratory Medicine & Pathobiology, University of Toronto, Toronto, Ontario, Canada.

Mathieu Lupien (M)

Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada. trevor.pugh@utoronto.ca mlupien@uhnresearch.ca.
Department of Medical Biophysics, University of Toronto, Toronto, Ontario, Canada.
Ontario Institute for Cancer Research, Toronto, Ontario, Canada.

Trevor J Pugh (TJ)

Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada. trevor.pugh@utoronto.ca mlupien@uhnresearch.ca.
Department of Medical Biophysics, University of Toronto, Toronto, Ontario, Canada.
Ontario Institute for Cancer Research, Toronto, Ontario, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH